Workup for Adolescents with Low Alkaline Phosphatase
The primary diagnostic consideration for an adolescent with low alkaline phosphatase is hypophosphatasia, which requires measurement of ALP substrates, genetic testing, and evaluation of bone mineralization.
Initial Diagnostic Approach
- Low alkaline phosphatase (ALP) in adolescents should prompt consideration of hypophosphatasia (HPP), a genetic disorder characterized by dysfunctional tissue-non-specific isoenzyme of ALP that impacts bone metabolism 1
- Confirm persistent low ALP with repeat testing, as transient hypophosphatasemia is common and may not be clinically significant 2
- Interpret ALP levels in the context of age-specific reference ranges, as adolescents typically have higher values due to active bone growth 3
Clinical Evaluation
Assess for history of:
Physical examination should focus on:
Laboratory Workup
First-line Tests
- Complete biochemical profile including:
Second-line Tests (if low ALP is confirmed)
Measure ALP substrates:
Calculate tubular maximum reabsorption of phosphate per glomerular filtration rate (TmP/GFR) to assess renal phosphate handling 6
Genetic testing for ALPL gene mutations to confirm diagnosis of HPP 5, 4
- Over 260 genetic mutations have been associated with HPP 5
Imaging Studies
Radiographic evaluation of:
Consider bone density testing (DXA scan) to evaluate bone mineralization 1
Differential Diagnosis
- Rule out other causes of low ALP:
Clinical Pearls and Pitfalls
- Pitfall: Normal total ALP does not exclude HPP - bone-specific ALP may be low while total ALP remains within normal range 4
- Pitfall: Adult and adolescent forms of HPP often present with milder manifestations than infantile forms, leading to delayed diagnosis 1, 5
- Pearl: Low ALP is a distinguishing sign of HPP, contrasting with most metabolic bone diseases which present with elevated ALP 5
- Pearl: Even asymptomatic patients with persistently low ALP should be evaluated for HPP, as early detection can prevent complications 2
Follow-up Recommendations
For confirmed HPP:
For patients with transient or unexplained low ALP: